Prospective study of HIV infection among parenteral drug abusers. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Prospective study of HIV infection among parenteral drug abusers.

J Subst Abuse. 1989;1(4):461-5. Unique Identifier : AIDSLINE MED/95078572
Cushman P Jr; Escobar M; Medical College of Virginia.

Abstract: Male heterosexual i.v. drug abusers in methadone maintenance treatment were surveyed for HIV disease and followed prospectively in Richmond, Virginia. Five of 50 (10%) had both positive ELISA and Western Blot antibodies initially, although none had other clinical manifestations. Forty-two (84%) were restudied 1 year later. None had developed clinical manifestations of HIV disease, or seroconverted from negative to positive. Thirty-nine Control i.v. drug abusers seeking methadone or inpatient detoxification showed a similar low seropositivity rate (3%), indicating that Richmond had low endemicity for HIV during the year. An unexpected finding in the followup of the 5 with initial seropositivity was that only 1 retained both ELISA and Western Blot positivity. The difference in serological reaction was unexplained.
Keywords: Adult Cross-Sectional Studies District of Columbia Human HIV Infections/*EPIDEMIOLOGY/PREVENTION & CONTROL/TRANSMISSION HIV Seropositivity/EPIDEMIOLOGY Incidence Male Middle Age Narcotic Dependence/COMPLICATIONS/*EPIDEMIOLOGY/REHABILITATION Prospective Studies Risk Factors Substance Abuse, Intravenous/COMPLICATIONS/*EPIDEMIOLOGY/ REHABILITATION Virginia/EPIDEMIOLOGY JOURNAL ARTICLEKWDadultcross-sectionalstudiesdistrictofcolumbiahumanhivinfections/KWDepidemiology/prevention&control/transmissionhivseropositivity/epidemiologyincidencemalemiddleagenarcoticdependence/complications/KWDepidemiology/rehabilitationprospectivestudiesriskfactorssubstanceabuse,intravenous/complications/KWDepidemiology/rehabilitationvirginia/epidemiologyjournalarticle
950330
M9530822

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .